1. Home
  2. TWAV vs DRMA Comparison

TWAV vs DRMA Comparison

Compare TWAV & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TaoWeave Inc. Common Stock

TWAV

TaoWeave Inc. Common Stock

N/A

Current Price

$1.36

Market Cap

4.9M

Sector

Technology

ML Signal

N/A

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

N/A

Current Price

$1.39

Market Cap

5.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWAV
DRMA
Founded
N/A
2014
Country
United States
United States
Employees
130
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.6M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
TWAV
DRMA
Price
$1.36
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
41.7K
464.4K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
90.77
N/A
EPS
0.43
N/A
Revenue
$2,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$650.00
P/E Ratio
$3.21
N/A
Revenue Growth
2.48
N/A
52 Week Low
$0.58
$0.95
52 Week High
$2.58
$6.22

Technical Indicators

Market Signals
Indicator
TWAV
DRMA
Relative Strength Index (RSI) 58.10 55.01
Support Level $1.11 $1.11
Resistance Level $1.45 $1.41
Average True Range (ATR) 0.10 0.14
MACD 0.01 0.02
Stochastic Oscillator 89.36 56.63

Price Performance

Historical Comparison
TWAV
DRMA

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: